ArticleGynecologic oncology2022

What proportion of patients with stage 3 ovarian cancer are potentially cured following intraperitoneal chemotherapy? Analysis of the long term (≥10 years) survivors in NRG/GOG randomized clinical trials of intraperitoneal and intravenous chemotherapy in stage III ovarian cancer.

Omali Pitiyarachchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.